Global Infectious Disease Molecular Diagnostics Market Size & Outlook
Global infectious disease molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Global infectious disease molecular diagnostics market highlights
- The global infectious disease molecular diagnostics market generated a revenue of USD 15,926.8 million in 2024 and is expected to reach USD 19,894.6 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 3.8% by 2030.
- In terms of segment, reagents product accounted for a revenue of USD 10,778.6 million in 2024.
- Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 15,926.8 million |
| Market revenue in 2030 | USD 19,894.6 million |
| Growth rate | 3.8% (CAGR from 2025 to 2030) |
| Largest segment | Reagents product |
| Fastest growing segment | Others Product |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments Product, Reagents Product, Others Product |
Other key industry trends
- In terms of revenue, the North America accounted for 41.0% of the global infectious disease molecular diagnostics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 899.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.68% in 2024. Horizon Databook has segmented the Global infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Infectious Disease Molecular Diagnostics Product Outlook (Revenue, USD Million, 2018-2030)
- Reagents Product
- Services Product
- Instruments Product
- Global Infectious Disease Molecular Diagnostics Test location Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Diagnostics Laboratories
- Research Institutes
- Clinics
- Global Infectious Disease Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- Polymerase Chain Reaction (PCR)
- Other PCR
- Multiplex PCR
- Instruments Multiplex PCR
- Reagents Multiplex PCR
- Others Multiplex PCR
- In Situ Hybridization
- Others In Situ Hybridization
- Instruments In Situ Hybridization
- Reagents In Situ Hybridization
- Mass spectrometry
- Reagents Mass spectrometry
- Instruments Mass spectrometry
- Others Mass spectrometry
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Instruments Isothermal Nucleic Acid Amplification Technology
- Reagents Isothermal Nucleic Acid Amplification Technology
- Others Isothermal Nucleic Acid Amplification Technology
- Chips and microarrays
- Others Chips and microarrays
- Instruments Chips and microarrays
- Reagents Chips and microarrays
- Transcription Mediated Amplification
- Reagents Transcription Mediated Amplification
- Instruments Transcription Mediated Amplification
- Others Transcription Mediated Amplification
- Others
- Instruments Others
- Reagents Others
- Others Others
- Polymerase Chain Reaction (PCR)
- Global Infectious Disease Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
- Tuberculosis
- HPV
- Sepsis
- Respiratory Diseases
- Sexually Transmitted Infection
- Gastrointestinal Tract Infections
- Meningitis
- Drug Resistance Disease
- Others Application
Reasons to subscribe to Global infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global infectious disease molecular diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global infectious disease molecular diagnostics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Infectious disease molecular diagnostics market size, 2024 (US$M)
Global infectious disease molecular diagnostics market share, by technology, 2024 & 2030 (%, US$M)
Infectious disease molecular diagnostics market: Opportunity assessment by country
Global infectious disease molecular diagnostics market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
